Rankings
▼
Calendar
VIR
Vir Biotechnology, Inc.
$1B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$605,000
-89.4% YoY
Gross Profit
$605,000
100.0% margin
Operating Income
-$159M
-26220.3% margin
Net Income
-$169M
-27919.2% margin
EPS (Diluted)
$-1.32
QoQ Revenue Growth
+101.0%
Cash Flow
Operating Cash Flow
-$90M
Free Cash Flow
-$90M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$485M
Stockholders' Equity
$651M
Cash & Equivalents
$521M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$605,000
$6M
-89.4%
Gross Profit
$605,000
-$52M
+101.2%
Operating Income
-$159M
-$72M
-120.6%
Net Income
-$169M
-$77M
-118.7%
Revenue Segments
Contract Revenue
$605,000
100%
← FY 2021
All Quarters
Q2 2021 →
VIR Q1 2021 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena